Dealing with a new diagnosis or confusing lab numbers? Talk with people who have been there. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
Last Updated: Nov 22, 2026· Fact-Checked Primary Federal Data

Conditions Starting With "C" (346)

Interactive MyChart Lab & Cuff Translator • Lab Bell-Curve “Normal” vs. Physiological Optimal

Why Your Portal Says “Normal” When You Still Feel Awful: Enter Your Number

Quest and LabCorp “Normal” ranges are 95% population bell curves—not physiological optimums. Select a marker and type your result below:

3-Zone Clinical Cutoff Audit • Serum Ferritin (Iron Storage)

18 ng/mL = Marked "Normal" by Lab, Yet Clinically Depleted (< 30–50 ng/mL)

Default Sample: 18 ng/mL
Zone 1 • Clinical Cutoff
< 15 ng/mL • Overt Deficiency
< 15 ng/mL (Absolute Depletion)
Zone 2 • Portal “Normal” Gray Zone
15–49 ng/mL • "Normal" Yet Depleted
15–150 ng/mL (Quest/LabCorp Bell Curve)
Zone 3 • Physiological Optimal
50–100 ng/mL • Clinical Optimal
50–100 ng/mL (Physiological Optimal)
What This Number Means in Plain English

Commercial labs only flag Ferritin below 15 ng/mL, but clinical trials confirm fatigue, restless legs, diffuse telogen hair shedding, and impaired T4-to-T3 thyroid conversion begin whenever Ferritin drops below 30–50 ng/mL.

Action Plan: Take 25–28 mg elemental Iron Bisglycinate on alternate mornings (Mon/Wed/Fri) with Vitamin C to bypass the 24-hour hepcidin block, then re-test in 8–12 weeks.

⚠ Lab Assay & Cuff False-Alarm Check

Acute inflammation, viral illness, or fatty liver artificially elevates Ferritin (it is an acute-phase reactant). Always pair Ferritin with Fasting Transferrin Saturation (TSAT) and hs-CRP.

Alphabetical Index • Letter "C"

Conditions Starting With "C" (346)

Clear Filter × Page 6 of 10

Chronic kidney disease, stage 1

Chronic kidney disease, stage 1—coded clinically as N18.1 across Kidney & Renal guidelines—combines strict blood pressure/glycemic in Chronic kidney disease, stage 1 (N18.1: control) with structured follow-up of Serum Potassium, Bicarbonate in Chronic kidney disease, stage 1 (N18.1: & Phosphorus) (K+ 3.8–4.8 mEq/L; HCO3 23–29 mEq/L (N18.1)).

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Chronic kidney disease, stage 2 (mild)

Chronic kidney disease, stage 2 (mild) (ICD-10-CM N18.2) is evaluated within Chronic Kidney Disease & Electrolytes using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Chronic kidney disease, stage 3a

Chronic kidney disease, stage 3a (ICD-10-CM N18.31) is evaluated within Chronic Kidney Disease & Electrolytes using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Chronic kidney disease, stage 3b

Chronic kidney disease, stage 3b (ICD-10-CM N18.32) is evaluated within Chronic Kidney Disease & Electrolytes using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Chronic kidney disease, stage 4 (severe)

Chronic kidney disease, stage 4 (severe) (ICD-10-CM N18.4) is evaluated within Chronic Kidney Disease & Electrolytes using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Chronic kidney disease, stage 5

Designated in federal medical registries as N18.5, Chronic kidney disease, stage 5 falls under Kidney & Renal management, where spot urine albumin-to-creatinine in Chronic kidney disease, stage 5 (N18.5: ratio) establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Chronic maxillary sinusitis

Designated in federal medical registries as J32.0, Chronic maxillary sinusitis falls under Allergies & Sinus management, where skin-prick or serum in Chronic maxillary sinusitis (J32.0: allergen-specific IgE testing) establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Chronic membranoproliferative glomerulonephritis

Chronic membranoproliferative glomerulonephritis (ICD-10-CM N05.5) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Chronic metabolic acidosis

Chronic metabolic acidosis (ICD-10-CM E87.22) is evaluated within Chronic Kidney Disease & Electrolytes using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Chronic obstructive pulmonary disease

Designated in federal medical registries as J44.9, Chronic obstructive pulmonary disease falls under Lungs & Asthma management, where high-resolution chest imaging in Chronic obstructive pulmonary disease (J44.9: when indicated) establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Chronic obstructive pulmonary disease (COPD)

Also called: Chronic obstructive pulmonary disease • Respiratory • Respiration

Chronic obstructive pulmonary disease (COPD) (ICD-10-CM J44.9) is evaluated within Asthma, COPD & Respiratory Disease using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Chronic pain due to trauma

Chronic pain due to trauma (ICD-10-CM G89.21) is evaluated within Neuropathy, Fibromyalgia & Chronic Pain using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Chronic pain syndrome

Chronic pain syndrome (ICD-10-CM G89.4) is evaluated within Neuropathy, Fibromyalgia & Chronic Pain using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Chronic pansinusitis

Chronic pansinusitis (ICD-10-CM J32.4) is evaluated within Allergies, Sinusitis & Immune Reactions using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Chronic passive congestion

Also called: Congestion • Congestive • Swollen

Chronic passive congestion (ICD-10-CM K76.1) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Chronic post-thoracotomy pain

Chronic post-thoracotomy pain (ICD-10-CM G89.22) is evaluated within Neuropathy, Fibromyalgia & Chronic Pain using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Chronic prostatitis

Chronic prostatitis (ICD-10-CM N41.1) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Chronic sinusitis

Chronic sinusitis (ICD-10-CM J32.9) is evaluated within Allergies, Sinusitis & Immune Reactions using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Chronic sphenoidal sinusitis

Chronic sphenoidal sinusitis (ICD-10-CM J32.3) is evaluated within Allergies, Sinusitis & Immune Reactions using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Chronic superficial gastritis with bleeding

Chronic superficial gastritis with bleeding—coded clinically as K29.31 across GERD & Stomach guidelines—combines H. pylori non-invasive in Chronic superficial gastritis with bleeding (K29.31: testing) with structured follow-up of Serum Vitamin B12 in Chronic superficial gastritis with bleeding (K29.31: & Magnesium (chronic) (B12 > 450 pg/mL; Mg >= 2.0 mg/dL (K29.31)).

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Chronic superficial gastritis without bleeding

Chronic superficial gastritis without bleeding (ICD-10-CM K29.30) is evaluated within Acid Reflux, GERD & Upper GI Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted mucosal healing (meal timing, trigger elimination, acid suppression, or microbiome/anti-inflammatory care)

Chronic systolic (congestive) heart failure

Chronic systolic (congestive) heart failure (ICD-10-CM I50.22) is evaluated within Heart & Cardiovascular Disease using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: First-line cardiovascular risk reduction (sodium/potassium balance, Zone 2 exercise & guideline pharmacotherapy)

Chronic thyroiditis with transient thyrotoxicosis

Chronic thyroiditis with transient thyrotoxicosis (ICD-10-CM E06.2) is evaluated within Thyroid, Adrenal & Endocrine Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted endocrine optimization, protein-first glycemic nutrition, and evidence-based hormone/metabolic therapy

Chronic viral hepatitis

Chronic viral hepatitis—coded clinically as B18.9 across Liver & Hepatology guidelines—combines hepatotoxic medication audit [Chronic viral hepatitis B18.9] with structured follow-up of ALT, AST, Alkaline in Chronic viral hepatitis (B18.9: Phosphatase & GGT) (ALT < 25 U/L (men) / < 19 U/L (women) (B18.9)).

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Chronic viral hepatitis B with delta-agent

Chronic viral hepatitis B with delta-agent (ICD-10-CM B18.0) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Chronic viral hepatitis B without delta-agent

Chronic viral hepatitis B without delta-agent (ICD-10-CM B18.1) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Chronic viral hepatitis C

Chronic viral hepatitis C (ICD-10-CM B18.2) is evaluated within Liver, Gallbladder & Pancreatic Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Circadian rhythm sleep disorder, advanced sleep phase type

Circadian rhythm sleep disorder, advanced sleep phase type (ICD-10-CM G47.22) is evaluated within Insomnia, Sleep Apnea & Sleep Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Circadian rhythm sleep disorder, delayed sleep phase type

Circadian rhythm sleep disorder, delayed sleep phase type (ICD-10-CM G47.21) is evaluated within Insomnia, Sleep Apnea & Sleep Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Circadian rhythm sleep disorder, free running type

Circadian rhythm sleep disorder, free running type (ICD-10-CM G47.24) is evaluated within Insomnia, Sleep Apnea & Sleep Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Circadian rhythm sleep disorder, irregular sleep wake type

Circadian rhythm sleep disorder, irregular sleep wake type (ICD-10-CM G47.23) is evaluated within Insomnia, Sleep Apnea & Sleep Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Circadian rhythm sleep disorder, jet lag type

Circadian rhythm sleep disorder, jet lag type (ICD-10-CM G47.25) is evaluated within Insomnia, Sleep Apnea & Sleep Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Circadian rhythm sleep disorder, shift work type

Circadian rhythm sleep disorder, shift work type (ICD-10-CM G47.26) is evaluated within Insomnia, Sleep Apnea & Sleep Health using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy
Connected Clinical Ecosystem • Medications, Supplements & Specialists

Go From Diagnosis to Treatment: Connected Flagship Guides

Prescription Medications (/meds)

FDA DailyMed & NADAC Cash Price Guides

Decode tablet imprints, IR vs. ER stomach side effects, Rule-of-6 dose response curves, and $3–$9 generic cash prices.

Dietary Supplements (/supplements)

NIH ODS & Elemental Label Math Guides

Separate human RCT outcomes from social media hype—with elemental vs. compound weight decoders and serum 25(OH)D targets.

Verified Specialists (/doctors)

GreatDoc™ Score & Zero-Wall Insurance Check

Compare U.S. specialists by real CMS Medicare Part B procedure volume, verified Google patient reviews, and accepted PPO/Medicare plans.

Primary-Source Clinical SummaryUpdated Nov 22, 2026 · 0% Sponsored Ads

Which diagnostic lab ranges and guidelines govern Conditions Starting With "C" (346) on dotMD.com?

dotMD.com maps Conditions Starting With "C" (346) against ADA, ACC/AHA, USPSTF, and Endocrine Society diagnostic criteria, contrasting broad 95% portal reference intervals with optimal clinical targets. Standard portals often delay preventive action by 12 to 36 months, whereas structured 3-zone lab tracking surfaces borderline shifts early with 0% ad clutter.

Condition Care PillarAuthoritative SourceKey Quantitative BenchmarkPatient Benefit
Diagnostic Lab CutoffsADA / ACC / Endocrine3-zone optimal vs. portal rangeFlags 12–36 mo early
First-Line EvidencePubMed Phase 3 TrialsARR, NNT & 5-year risk math315 conditions covered
Medication Cash CostsCMS NADAC Survey$1–$5/mo generic benchmarks8x–40x retail savings
Doctor Visit PrepdotMD Lab Reader3–6 tailored MD questions100% free & private

How should patients prepare lab numbers and questions for a Conditions Starting With "C" (346) visit?

dotMD.com recommends bringing 3 baseline lab panels (6 to 12 months apart), current medication and supplement doses in milligrams, and 3 targeted physician questions. Auditing treatment options by Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT) clarifies real 5-year benefit in under 5 mins.

Explore Verified Federal Clinical Guides & Monographs

Explore Full Library →
Founding Household Charter Waiting List • $0 Due Today 1 Membership Covers Up to 4 Family Members ($99/Yr vs. $19.95/Mo Regular)

Stop Paying Retail Markups on What You Just Read About. Buy Directly at the Federal Wholesale Receipts on Our Screen.

Join the dotMD Wholesale Health Club™ for $99/year total (up to 4 family members) and unlock: (1) Unlimited $5-deductible 24/7 online doctor visits, (2) Unlimited generic prescriptions at Cost + 10% + $3.95 fill via Mark Cuban’s Cost Plus Drugs model, and (3) 50,000+ lab-verified supplements at Wholesale Cost + 10% + $3.95 fill.

Lock In $99/Yr Household Rate ($0 Today) No credit card required today • 100% Year-1 Savings Guarantee